Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Breast 3 Lymphoid 2 Endocrine 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Other 1 Head & Neck 1 Gynecologic 1

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 581 Carboplatin 528 Cisplatin 359 Bevacizumab 256 pembrolizumab 228 Gemcitabine 157 liposomal doxorubicin 132 Topotecan 131 olaparib 129 Cyclophosphamide 128 Radiotherapy 118 Taxes 114 Docetaxel 95 Brachytherapy 94 Drug Therapy 91 niraparib 88 Doxorubicin 86 Surveys and Questionnaires 85 Magnetic Resonance Spectroscopy 80 Blood Specimen Collection 74 Nivolumab 71 Specimen Handling 70 Hyperthermic Intraperitoneal Chemotherapy 64 Biopsy 63 fludarabine 57 Filgrastim 53 Letrozole 50 Oxaliplatin 49 durvalumab 47 Immunoglobulin G 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lansoprazole × Gynecologic × Clear all

NCT03192059 2021-09-08

PRIMMO

University Hospital, Ghent

Phase 2 Completed

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡